{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T14:55:42Z","timestamp":1793804142199,"version":"4.6.1"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2018,11]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>\n                      There is a need for an alternative PET probe, which does not show normal brain tissue uptake in the evaluation of metastasis to the brain. Therefore, we investigate the feasibility of\n                      <jats:sup>18<\/jats:sup>\n                      F-labeled glutamine analog,\n                      <jats:sup>18<\/jats:sup>\n                      F-(2S,4\n                      <jats:italic toggle=\"yes\">R<\/jats:italic>\n                      )-4-fluoroglutamine (\n                      <jats:sup>18<\/jats:sup>\n                      F-FGln), as a new metabolic probe to detect brain metastasis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Patients (7 men and 7 women; age, 25\u201367 years) with suspected brain metastasis were enrolled for this study. All patients were imaged first with\n                      <jats:sup>18<\/jats:sup>\n                      F-FGln PET (3 patients for 1-hour dynamic whole-body PET\/CT scans, and 11 patients for static whole-body scans at 30 \u00b1 10 minutes after injection), followed by a whole-body\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET performed in the same week. The characteristics of\n                      <jats:sup>18<\/jats:sup>\n                      F-FGln PET imaging in brain metastasis patients were compared with that of\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET and\/or contrast-enhanced MRI patient-by-patient. A composite of all functional and anatomic imaging studies served as the imaging comparator.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Initial study in 3 patients using 1-hour dynamic scan showed that 30 \u00b1 10 minutes after injection is optimal for identifying brain metastasis with a high-contrast ratio. All patients were positive for brain metastasis on this studies that demonstrated 38 lesions in 6 anatomic regions on the imaging comparator. The per-lesion detection rates for\n                      <jats:sup>18<\/jats:sup>\n                      F-FGln PET and\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET were 81.6% and 36.8%, respectively. The average tumor-to-normal brain ratio of\n                      <jats:sup>18<\/jats:sup>\n                      F-FGln PET was significantly better than that of\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET in all patients (4.97 \u00b1 2.23 vs 1.22 \u00b1 0.69,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05). Furthermore, our results suggest that\n                      <jats:sup>18<\/jats:sup>\n                      F-FGln uptake in brain metastasis appeared to be independent of tumor size and peripheral edema. In addition, in 14 brain metastatic lesions visualized by both\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET and\n                      <jats:sup>18<\/jats:sup>\n                      F-FGln PET imaging, a positive correlation of SUV\n                      <jats:sub>max<\/jats:sub>\n                      was observed (\n                      <jats:italic toggle=\"yes\">r<\/jats:italic>\n                      = 0.780,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.01). As to the extracranial metastasis, both tracers showed a concordant increased radioactive uptake except in liver and bone.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      The initial imaging of\n                      <jats:sup>18<\/jats:sup>\n                      F-FGln presenting a promising new PET radiotracer for patients with brain metastasis and its utility in the liver and bone metastatic lesions may require more caution due to uptake in normal structures.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/rlu.0000000000002257","type":"journal-article","created":{"date-parts":[[2018,9,2]],"date-time":"2018-09-02T18:23:53Z","timestamp":1535912633000},"page":"e392-e399","source":"Crossref","is-referenced-by-count":28,"title":["Imaging Brain Metastasis Patients With 18F-(2S,4R)-4-Fluoroglutamine"],"prefix":"10.1097","volume":"43","author":[{"given":"Xiaoxia","family":"Xu","sequence":"first","affiliation":[{"name":"Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education\/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhu","sequence":"additional","affiliation":[{"name":"Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education\/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Liu","sequence":"additional","affiliation":[{"name":"Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education\/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Radiopharmaceuticals, Ministry of Education, College of Chemistry, Beijing Normal University, Beijing, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Yang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education\/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Radiopharmaceuticals, Ministry of Education, College of Chemistry, Beijing Normal University, Beijing, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhu","sequence":"additional","affiliation":[{"name":"Key Laboratory of Radiopharmaceuticals, Ministry of Education, College of Chemistry, Beijing Normal University, Beijing, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Li","sequence":"additional","affiliation":[{"name":"Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education\/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hank F.","family":"Kung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Yang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education\/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"bib1-20230925","doi-asserted-by":"crossref","first-page":"60581","DOI":"10.18632\/oncotarget.19943","article-title":"Fluorine-18 labeled amino acids for tumor PET\/CT imaging","volume":"8","year":"2017","journal-title":"Oncotarget"},{"key":"bib2-20230925","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/00003072-200010000-00008","article-title":"Imaging of malignant lymphomas with F-18 FDG coincidence detection positron emission tomography","volume":"25","year":"2000","journal-title":"Clin Nucl Med"},{"key":"bib3-20230925","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1158\/0008-5472.CAN-09-3556","article-title":"Rethinking the Warburg effect with Myc micromanaging glutamine metabolism","volume":"70","year":"2010","journal-title":"Cancer Res"},{"key":"bib4-20230925","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","year":"2009","journal-title":"Science"},{"issue":"Suppl 2","key":"bib5-20230925","doi-asserted-by":"crossref","first-page":"24S","DOI":"10.2967\/jnumed.107.047258","article-title":"Causes and consequences of increased glucose metabolism of cancers","volume":"49","year":"2008","journal-title":"J Nucl Med"},{"issue":"Suppl 2","key":"bib6-20230925","first-page":"1S","article-title":"Molecualr imaging of cancer: from molecules to humans. Introduction","volume":"49","year":"2008","journal-title":"J Nucl Med"},{"key":"bib7-20230925","first-page":"125","article-title":"Brain metastases detectability of routine whole body (18)F-FDG PET and low dose CT scanning in 2502 asymptomatic patients with solid extracranial tumors","volume":"15","year":"2012","journal-title":"Hell J Nucl Med"},{"key":"bib8-20230925","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/00003072-200105000-00006","article-title":"Detection of cranial metastases by F-18 FDG positron emission tomography","volume":"26","year":"2001","journal-title":"Clin Nucl Med"},{"key":"bib9-20230925","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ccr.2012.02.014","article-title":"Metabolic reprogramming: a cancer hallmark even warburg did not anticipate","volume":"21","year":"2012","journal-title":"Cancer Cell"},{"key":"bib10-20230925","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1148\/radiol.2017162610","article-title":"In vivo PET assay of tumor glutamine flux and metabolism: in-human trial of 18F-(2S,4R)-4-fluoroglutamine","volume":"287","year":"2018","journal-title":"Radiology"},{"key":"bib11-20230925","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.2967\/jnumed.111.093815","article-title":"PET imaging of glutaminolysis in tumors by 18F-(2S,4R)4-fluoroglutamine","volume":"52","year":"2011","journal-title":"J Nucl Med"},{"key":"bib12-20230925","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.2967\/jnumed.111.101279","article-title":"Comparative evaluation of 18F-labeled glutamic acid and glutamine as tumor metabolic imaging agents","volume":"53","year":"2012","journal-title":"J Nucl Med"},{"key":"bib13-20230925","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1021\/ja109203d","article-title":"Synthesis of optically pure 4-fluoro-glutamines as potential metabolic imaging agents for tumors","volume":"133","year":"2011","journal-title":"J Am Chem Soc"},{"key":"bib14-20230925","first-page":"274ra217","article-title":"Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo","volume":"7","year":"2015","journal-title":"Sci Transl Med"},{"key":"bib15-20230925","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00259-017-3896-9","article-title":"Superiority of 68Ga-DOTATATE over 18F-FDG and anatomic imaging in the detection of succinate dehydrogenase mutation (SDHx )-related pheochromocytoma and paraganglioma in the pediatric population","volume":"45","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib16-20230925","first-page":"B4944","article-title":"The prognostic value of clinical factors and cancer stem cell-related markers in gliomas","volume":"61","year":"2014","journal-title":"Dan Med J"},{"key":"bib17-20230925","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2967\/jnumed.107.047290","article-title":"Whole-body biodistribution and radiation dosimetry of the human cannabinoid type-1 receptor ligand 18F-MK-9470 in healthy subjects","volume":"49","year":"2008","journal-title":"J Nucl Med"},{"key":"bib18-20230925","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S1042-3680(18)30369-3","article-title":"Imaging of cerebral metastases","volume":"7","year":"1996","journal-title":"Neurosurg Clin N Am"},{"key":"bib19-20230925","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3171\/jns.1979.51.1.0053","article-title":"Capillary ultrastructure in human metastatic brain tumors","volume":"51","year":"1979","journal-title":"J Neurosurg"},{"key":"bib20-20230925","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.ijrobp.2009.06.030","article-title":"The effect of early detection of occult brain metastases in HER2-positive breast cancer patients on survival and cause of death","volume":"77","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"bib21-20230925","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.crad.2009.09.005","article-title":"Solitary metastases and high-grade gliomas: radiological differentiation by morphometric analysis and perfusion-weighted MRI","volume":"65","year":"2010","journal-title":"Clin Radiol"},{"key":"bib22-20230925","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1148\/radiol.2223010558","article-title":"High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging","volume":"222","year":"2002","journal-title":"Radiology"},{"key":"bib23-20230925","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1038\/sj.jcbfm.9600490","article-title":"Glutamatergic and GABAergic neurotransmitter cycling and energy metabolism in rat cerebral cortex during postnatal development","volume":"27","year":"2007","journal-title":"J Cereb Blood Flow Metab"},{"key":"bib24-20230925","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1742-4682-4-48","article-title":"Reconstruction and flux analysis of coupling between metabolic pathways of astrocytes and neurons: application to cerebral hypoxia","volume":"4","year":"2007","journal-title":"Theor Biol Med Model"},{"key":"bib25-20230925","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.cell.2014.11.025","article-title":"Acetate is a bioenergetic substrate for human glioblastoma and brain metastases","volume":"159","year":"2014","journal-title":"Cell"},{"key":"bib26-20230925","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1479-5876-12-2","article-title":"Metabolic phenotypes in primary unknown metastatic carcinoma","volume":"12","year":"2014","journal-title":"J Transl Med"},{"key":"bib27-20230925","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The emerging hallmarks of cancer metabolism","volume":"23","year":"2016","journal-title":"Cell Metab"},{"key":"bib28-20230925","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s10143-016-0756-1","article-title":"Molecular imaging of brain tumors with radiolabeled choline PET","volume":"41","year":"2018","journal-title":"Neurosurg Rev"},{"key":"bib29-20230925","doi-asserted-by":"crossref","first-page":"e196","DOI":"10.1097\/RLU.0b013e31824c5dd0","article-title":"Distribution patterns of 18F-labelled fluoromethylcholine in normal structures and tumors of the head: a PET\/MRI evaluation","volume":"37","year":"2012","journal-title":"Clin Nucl Med"},{"key":"bib30-20230925","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.3174\/ajnr.A1008","article-title":"Metabolic assessment of gliomas using 11C-methionine, [18F] fluorodeoxyglucose, and 11C-choline positron-emission tomography","volume":"29","year":"2008","journal-title":"AJNR Am J Neuroradiol"},{"key":"bib31-20230925","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/RLU.0b013e3182175840","article-title":"Comparison of C-11 methionine and C-11 choline for PET imaging of brain metastases: a prospective pilot study","volume":"36","year":"2011","journal-title":"Clin Nucl Med"},{"key":"bib32-20230925","doi-asserted-by":"crossref","first-page":"608","DOI":"10.2967\/jnumed.106.036251","article-title":"Uptake of 18F-Fluorocholine, 18F-FET, and 18F-FDG in C6 gliomas and correlation with 131I-SIP(L19), a marker of angiogenesis","volume":"48","year":"2007","journal-title":"J Nucl Med"},{"key":"bib33-20230925","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1097\/RLU.0b013e3181becfe0","article-title":"Comparative evaluation of F-18 FDOPA, F-18 FDG, and F-18 FLT-PET\/CT for metabolic imaging of low grade gliomas","volume":"34","year":"2009","journal-title":"Clin Nucl Med"},{"key":"bib34-20230925","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/MNM.0b013e328351d566","article-title":"Molecular imaging of brain tumors with 18F-DOPA PET and PET\/CT","volume":"33","year":"2012","journal-title":"Nucl Med Commun"},{"key":"bib35-20230925","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1097\/RLU.0b013e3182485172","article-title":"18F-DOPA PET\/CT in neuroblastoma: comparison of conventional imaging with CT\/MR","volume":"37","year":"2012","journal-title":"Clin Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003072-201811000-00027","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T01:08:13Z","timestamp":1695604093000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201811000-00027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000002257","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]}}}